Ryan Langley, a partner of the Spartanburg-based firm Hodge & Langley Law Firm, P.C., has been accepted into the American Board of Trial Advocates (ABOTA).
ABOTA dedicates itself to the preservation and promotion of the Seventh Amendment, which guarantees the right to civil jury trials. Members in this prestigious invitation-only group must have tried a minimum of 10 civil jury trials to conclusion. More than 7,600 lawyers and judges are involved in ABOTA chapters in all 50 states.
"ABOTA is one of the nation's most effective organizations in championing the ethics, professionalism and principles of the legal profession, and I'm honored to be part of this select group," Mr. Langley said.
Mr. Langley represents clients in all types of wrongful death and catastrophic physical or business injury disputes in federal and state courts throughout South Carolina, North Carolina, Georgia and the United States.
Mr. Langley's litigation experience includes over a dozen trials to verdict in state and federal matters, multiple arguments before the South Carolina Supreme Court, and oral argument before the United States Court of Appeals for the 4th Circuit.
A graduate of the University of South Carolina School of Law with undergraduate degree from Wofford College, Mr. Langley has earned recognition on the South Carolina Rising Star Super Lawyers list each year since 2012. He is AV-rated Preeminent by professional peer-review through Martindale-Hubbell. Mr. Langley is also a Fellow in the International Society of Barristers, an organization dedicated to protecting the rights of citizens, the independence of the judiciary, and the integrity of the Bar.
The lawyers and staff at Hodge & Langley Law Firm take pride in close client communication and personal advocacy. The firm focuses its practice on high-stakes wrongful death and catastrophic physical and business litigation matters in South Carolina, North Carolina, and Georgia. The firm also represents claimants in nationwide multi-district litigation on complex matters including dangerous and defective pharmaceuticals and medical devices.